Medicis Pharmaceutical Corp. and Ipsen announced Thursday morning that the FDA approved DYSPORT for two separate indications.
Medicis Pharmaceutical Corp. gapped open higher Thursday and climbed above the day's narrow range going into the close. The stock finished up by $2.50 at $16.07 on above average volume. The stock broke out to a 7-month high and re-crossed its 200-day moving average.
For full details on Medicis Pharmaceutical A (MRX) click here. Medicis Pharmaceutical A (MRX) has Short Term PowerRatings of 4. Details on Medicis Pharmaceutical A (MRX) Short Term PowerRatings is available at This Link.
No comments:
Post a Comment